Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases

Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing and therefore is its burden of disease as NALFD is a risk factor for cirrhosis and is associated with other metabolic conditions such as type II diabetes, obesity, dyslipidaemia and atherosclerosis. Linking these cardiometabol...

Full description

Bibliographic Details
Main Authors: Charlotte Teunis, Max Nieuwdorp, Nordin Hanssen
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Metabolites
Subjects:
NAFLD
MAFLD
metabolic disease
gut microbiota
tryptophan metabolism
Online Access:https://www.mdpi.com/2218-1989/12/6/514

Internet

https://www.mdpi.com/2218-1989/12/6/514

Similar Items